Kura Oncology
(NASDAQ) KURA
Kura Oncology Financials at a Glance
Market Cap
$760.52M
Revenue (TTM)
$67.48M
Net Income (TTM)
$278.67M
EPS (TTM)
$-3.18
P/E Ratio
-2.71
Dividend
$0.00
Beta (Volatility)
1.08 (Average)
Dividend
$0.00
Beta (Volatility)
1.08 (Average)
Price
$8.61
Volume
4,391,977.238
Open
$8.15
Price
$8.61
Volume
4,391,977.238
Open
$8.15
Previous Close
$8.61
Daily Range
$8.15 - $8.94
52-Week Range
$5.41 - $12.49
Dividend
$0.00
Beta (Volatility)
1.08 (Average)
Price
$8.61
Volume
4,391,977.238
Open
$8.15
Previous Close
$8.61
Daily Range
$8.15 - $8.94
52-Week Range
$5.41 - $12.49
KURA News
KURA: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Kura Oncology
Industry
Biotechnology
Sector
Health CareEmployees
260
CEO
Troy E. Wilson, PhD
Website
www.kuraoncology.comHeadquarters
San Diego, CA 92130, US
KURA Financials
Key Financial Metrics (TTM)
Gross Margin
95%
Operating Margin
-4%
Net Income Margin
-4%
Return on Equity
-95%
Return on Capital
-49%
Return on Assets
-38%
Earnings Yield
-36.90%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$760.52M
Shares Outstanding
88.33M
Volume
4.39M
Short Interest
0.00%
Avg. Volume
1.53M
Financials (TTM)
Gross Profit
$67.42M
Operating Income
$303.63M
EBITDA
$303.63M
Operating Cash Flow
$64.06M
Capital Expenditure
$6.64M
Free Cash Flow
$70.70M
Cash & ST Invst.
$667.24M
Total Debt
$20.46M
Kura Oncology Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$17.34M
-67.8%
Gross Profit
$16.88M
-68.7%
Gross Margin
97.35%
N/A
Market Cap
$760.52M
N/A
Market Cap/Employee
$3.96M
N/A
Employees
192
N/A
Net Income
$81.00M
-321.5%
EBITDA
$85.86M
-417.5%
Quarterly Fundamentals
Net Cash
$646.78M
-9.0%
Accounts Receivable
$12.60M
N/A
Inventory
$413.00K
N/A
Long Term Debt
$19.18M
+58.4%
Short Term Debt
$1.28M
-71.5%
Return on Assets
-37.74%
N/A
Return on Invested Capital
-48.86%
N/A
Free Cash Flow
$114.95M
-57.2%
Operating Cash Flow
$117.27M
-56.4%